Intensity and duration of amnesia from intravenous midazolam given for sedation.
Hupp, J R; Becker, L E.
J Conn State Dent Assoc
; 62(2): 80-5, 1988.
Artigo em Inglês | MEDLINE | ID: mdl-3152521
Disposition of midazolam in asphyxiated neonates receiving therapeutic hypothermia--a pilot study.
Effect of the active ingredient of Kaempferia parviflora, 5,7-dimethoxyflavone, on the pharmacokinetics of midazolam.
Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers.
Challenging the Relevance of Unbound Tissue-to-Blood Partition Coefficient (Kp<sub>uu</sub>) on Prediction of Drug-Drug Interactions.
Pharmacokinetics of ginkgolides A, B and K after single and multiple intravenous infusions and their interactions with midazolam in healthy Chinese male subjects.
Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?
Sedation, analgesia, and cardiorespiratory function in colonoscopy using midazolam combined with fentanyl or propofol.
Midazolam Dose Optimization in Critically Ill Pediatric Patients With Acute Respiratory Failure: A Population Pharmacokinetic-Pharmacogenomic Study.
Factors Affecting the Absorption of Midazolam to the Extracorporeal Membrane Oxygenation Circuit.
Plasma concentration based response surface model predict better than effect-site concentration based model for wake-up time during gastrointestinal endoscopy sedation.